People on the Move
Novo Nordisk promoted EVP Lars Jørgensen to CEO and announces changeover in Novo US
As EVP of Corporate Development, Lars Fruergaard Jørgensen will now replace Lars Rebien Sørensen as Novo Nordisk’s president and CEO, following Sørensen’s retirement in December.
Also effective today (March 1) Jakob Riis, executive VP, head of North America Operations and president of Novo Nordisk Inc. has resigned from the company.
Replacing Jakob, Doug Langa, SVP for Market Access at Novo Nordisk has been appointed as SVP, head of North America Operations and president of Novo Nordisk Inc. Doug will report to Jørgensen.
As a Danish national, Jørgensen joined Novo in 1991, serving various roles across the US, Netherlands and Japan. He is also chairman of the board of NNE Pharmaplan A/S, Denmark.
